Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer

Adjuvant androgen suppression, bisphosphonates and increasing EBRT dose did not increase rectal or urinary dysfunction in this trial. However dose escalation using HDRB increased urinary dysfunction.